Last 12 months
Inside the activity.
0 purchase rows · 35 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 2 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 16 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 17 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 30, 2019 Filed Nov 1, 2019 21:04 UTC |
Scholefield James HEVP,Chief Info&Digital Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 11,436 | $85.10 | $973,203.60 |
DisclosureSEC source: 0001225208-19-014013 · doc4.xml · derivative · entry 3 Scholefield James H · CIK 0001720922 · EVP,Chief Info&Digital Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,872 Underlying: Common Stock · 11,436 shares Expires 2021-10-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock. F2 · derivative.exercise_date: These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 10/30/2019, 10/30/2020 and 10/30/2021. Read SEC document |
| October 30, 2019 Filed Nov 1, 2019 21:04 UTC |
Scholefield James HEVP,Chief Info&Digital Officer
|
Tax withholdingCommon Stock | 4,294 | $85.10 | $365,419.40 |
DisclosureSEC source: 0001225208-19-014013 · doc4.xml · nonDerivative · entry 2 Scholefield James H · CIK 0001720922 · EVP,Chief Info&Digital Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,142 Read SEC document |
| October 30, 2019 Filed Nov 1, 2019 21:04 UTC |
Scholefield James HEVP,Chief Info&Digital Officer
|
Exercise / conversionCommon Stock | 11,436 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-19-014013 · doc4.xml · nonDerivative · entry 1 Scholefield James H · CIK 0001720922 · EVP,Chief Info&Digital Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,436 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 30, 2019 Filed Nov 1, 2019 21:06 UTC |
Clyburn FrankEVP, Chief Commercial Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 2,287 | $85.10 | $194,623.70 |
DisclosureSEC source: 0001225208-19-014014 · doc4.xml · derivative · entry 4 Clyburn Frank · CIK 0001763963 · EVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,575 Underlying: Common Stock · 2,287 shares Expires 2021-10-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock. F4 · derivative.exercise_date: These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 10/30/2019, 10/30/2020 and 10/30/2021. Read SEC document |
| October 30, 2019 Filed Nov 1, 2019 21:06 UTC |
Clyburn FrankEVP, Chief Commercial Officer
|
Tax withholdingCommon Stock | 1,127 | $85.10 | $95,907.70 |
DisclosureSEC source: 0001225208-19-014014 · doc4.xml · nonDerivative · entry 2 Clyburn Frank · CIK 0001763963 · EVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,904.968 F1 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| October 30, 2019 Filed Nov 1, 2019 21:06 UTC |
Clyburn FrankEVP, Chief Commercial Officer
|
Exercise / conversionCommon Stock | 2,287 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-19-014014 · doc4.xml · nonDerivative · entry 1 Clyburn Frank · CIK 0001763963 · EVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,031.968 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 30, 2019 Filed Nov 1, 2019 21:07 UTC |
Nally MichaelEVP, Chief Marketing Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 2,287 | $85.10 | $194,623.70 |
DisclosureSEC source: 0001225208-19-014015 · doc4.xml · derivative · entry 4 Nally Michael · CIK 0001763945 · EVP, Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,575 Underlying: Common Stock · 2,287 shares Expires 2021-10-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock. F4 · derivative.exercise_date: These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 10/30/2019, 10/30/2020 and 10/30/2021. Read SEC document |
| October 30, 2019 Filed Nov 1, 2019 21:07 UTC |
Nally MichaelEVP, Chief Marketing Officer
|
Tax withholdingCommon Stock | 652 | $85.10 | $55,485.20 |
DisclosureSEC source: 0001225208-19-014015 · doc4.xml · nonDerivative · entry 2 Nally Michael · CIK 0001763945 · EVP, Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,543.71 F1 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| October 30, 2019 Filed Nov 1, 2019 21:07 UTC |
Nally MichaelEVP, Chief Marketing Officer
|
Exercise / conversionCommon Stock | 2,287 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-19-014015 · doc4.xml · nonDerivative · entry 1 Nally Michael · CIK 0001763945 · EVP, Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,195.71 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 30, 2019 Filed Nov 1, 2019 21:07 UTC |
MIZELL STEVENEVP, Chief HR Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 4,574 | $85.10 | $389,247.40 |
DisclosureSEC source: 0001225208-19-014016 · doc4.xml · derivative · entry 3 MIZELL STEVEN · CIK 0001189403 · EVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,149 Underlying: Common Stock · 4,574 shares Expires 2021-10-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock. F2 · derivative.exercise_date: These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 10/30/2019, 10/30/2020 and 10/30/2021. Read SEC document |
| October 30, 2019 Filed Nov 1, 2019 21:07 UTC |
MIZELL STEVENEVP, Chief HR Officer
|
Tax withholdingCommon Stock | 1,567 | $85.10 | $133,351.70 |
DisclosureSEC source: 0001225208-19-014016 · doc4.xml · nonDerivative · entry 2 MIZELL STEVEN · CIK 0001189403 · EVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,007 Read SEC document |
| October 30, 2019 Filed Nov 1, 2019 21:07 UTC |
MIZELL STEVENEVP, Chief HR Officer
|
Exercise / conversionCommon Stock | 4,574 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-19-014016 · doc4.xml · nonDerivative · entry 1 MIZELL STEVEN · CIK 0001189403 · EVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,574 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 30, 2019 Filed Oct 2, 2019 21:09 UTC |
Coe Mary EllenDirector
|
GrantPhantom Stock · Derivative | 371.2283 | $84.18 | $31,250.00 |
DisclosureSEC source: 0001127602-19-029755 · form4.xml · derivative · entry 2 Coe Mary Ellen · CIK 0001691304 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,230.8593 Underlying: Common Stock · 371.2283 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| September 30, 2019 Filed Oct 2, 2019 21:12 UTC |
GLOCER THOMAS HDirector
|
GrantPhantom Stock · Derivative | 200.4633 | $84.18 | $16,875.00 |
DisclosureSEC source: 0001127602-19-029759 · form4.xml · derivative · entry 2 GLOCER THOMAS H · CIK 0001140799 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,688.2863 Underlying: Common Stock · 200.4633 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| September 30, 2019 Filed Oct 2, 2019 21:18 UTC |
LAZARUS ROCHELLE BDirector
|
GrantPhantom Stock · Derivative | 341.5301 | $84.18 | $28,750.00 |
DisclosureSEC source: 0001127602-19-029768 · form4.xml · derivative · entry 3 LAZARUS ROCHELLE B · CIK 0001082206 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,739.5121 Underlying: Common Stock · 341.5301 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| September 30, 2019 Filed Oct 2, 2019 21:20 UTC |
WEEKS WENDELL PDirector
|
GrantPhantom Stock · Derivative | 341.5301 | $84.18 | $28,750.00 |
DisclosureSEC source: 0001127602-19-029770 · form4.xml · derivative · entry 2 WEEKS WENDELL P · CIK 0001206158 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,564.2611 Underlying: Common Stock · 341.5301 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| September 30, 2019 Filed Oct 2, 2019 21:24 UTC |
Wendell Peter CDirector
|
GrantPhantom Stock · Derivative | 341.5301 | $84.18 | $28,750.00 |
DisclosureSEC source: 0001127602-19-029772 · form4.xml · derivative · entry 2 WENDELL PETER C · CIK 0001032635 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,631.4181 Underlying: Common Stock · 341.5301 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| August 09, 2019 Filed Aug 12, 2019 21:13 UTC |
DeLuca Richard R.EVP&Pres, Merck Animal Heallth
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 6,427 | $0.00 Strike: $39.29 | $0.00 |
DisclosureSEC source: 0001127602-19-026430 · form4.xml · derivative · entry 7 DeLuca Richard R. · CIK 0001421339 · EVP&Pres, Merck Animal Heallth 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,427 shares Expires 2022-05-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The option became exercisable in equal installments on 5/2/2013, 5/2/2014 and 5/2/2015. Read SEC document |
| August 09, 2019 Filed Aug 12, 2019 21:13 UTC |
DeLuca Richard R.EVP&Pres, Merck Animal Heallth
|
SaleCommon Stock | 6,427 | $85.09 | $546,849.65 |
DisclosureSEC source: 0001127602-19-026430 · form4.xml · nonDerivative · entry 4 DeLuca Richard R. · CIK 0001421339 · EVP&Pres, Merck Animal Heallth 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,523.81 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $85.0500 to $85.1450, inclusive. The reporting person undertakes to provide to Merck & Co., Inc., any security holder of Merck & Co., Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above in this footnote. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| August 09, 2019 Filed Aug 12, 2019 21:13 UTC |
DeLuca Richard R.EVP&Pres, Merck Animal Heallth
|
Exercise / conversionCommon Stock | 6,427 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-026430 · form4.xml · nonDerivative · entry 3 DeLuca Richard R. · CIK 0001421339 · EVP&Pres, Merck Animal Heallth 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,950.81 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 08, 2019 Filed Aug 12, 2019 21:13 UTC |
DeLuca Richard R.EVP&Pres, Merck Animal Heallth
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 31,699 | $0.00 Strike: $39.29 | $0.00 |
DisclosureSEC source: 0001127602-19-026430 · form4.xml · derivative · entry 6 DeLuca Richard R. · CIK 0001421339 · EVP&Pres, Merck Animal Heallth 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,427 Underlying: Common Stock · 31,699 shares Expires 2022-05-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The option became exercisable in equal installments on 5/2/2013, 5/2/2014 and 5/2/2015. Read SEC document |
| August 08, 2019 Filed Aug 12, 2019 21:13 UTC |
DeLuca Richard R.EVP&Pres, Merck Animal Heallth
|
SaleCommon Stock | 31,699 | $85.01 | $2,694,789.05 |
DisclosureSEC source: 0001127602-19-026430 · form4.xml · nonDerivative · entry 2 DeLuca Richard R. · CIK 0001421339 · EVP&Pres, Merck Animal Heallth 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,523.81 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $85.0000 to $85.0450, inclusive. The reporting person undertakes to provide to Merck & Co., Inc., any security holder of Merck & Co., Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above in this footnote. Read SEC document |
| August 08, 2019 Filed Aug 12, 2019 21:13 UTC |
DeLuca Richard R.EVP&Pres, Merck Animal Heallth
|
Exercise / conversionCommon Stock | 31,699 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-026430 · form4.xml · nonDerivative · entry 1 DeLuca Richard R. · CIK 0001421339 · EVP&Pres, Merck Animal Heallth 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,222.81 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 28, 2019 Filed Jul 2, 2019 21:01 UTC |
Coe Mary EllenDirector
|
GrantPhantom Stock · Derivative | 372.6893 | $83.85 | $31,250.00 |
DisclosureSEC source: 0001127602-19-023644 · form4.xml · derivative · entry 2 Coe Mary Ellen · CIK 0001691304 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,843.461 Underlying: Common Stock · 372.6893 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| June 28, 2019 Filed Jul 2, 2019 21:10 UTC |
GLOCER THOMAS HDirector
|
GrantPhantom Stock · Derivative | 201.2522 | $83.85 | $16,875.00 |
DisclosureSEC source: 0001127602-19-023672 · form4.xml · derivative · entry 2 GLOCER THOMAS H · CIK 0001140799 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,056.8309 Underlying: Common Stock · 201.2522 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| June 28, 2019 Filed Jul 2, 2019 21:13 UTC |
LAZARUS ROCHELLE BDirector
|
GrantPhantom Stock · Derivative | 342.8742 | $83.85 | $28,750.00 |
DisclosureSEC source: 0001127602-19-023679 · form4.xml · derivative · entry 3 LAZARUS ROCHELLE B · CIK 0001082206 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,844.9579 Underlying: Common Stock · 342.8742 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| June 28, 2019 Filed Jul 2, 2019 21:15 UTC |
WEEKS WENDELL PDirector
|
GrantPhantom Stock · Derivative | 342.8742 | $83.85 | $28,750.00 |
DisclosureSEC source: 0001127602-19-023690 · form4.xml · derivative · entry 2 WEEKS WENDELL P · CIK 0001206158 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,638.3359 Underlying: Common Stock · 342.8742 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| June 28, 2019 Filed Jul 2, 2019 21:17 UTC |
Wendell Peter CDirector
|
GrantPhantom Stock · Derivative | 342.8742 | $83.85 | $28,750.00 |
DisclosureSEC source: 0001127602-19-023698 · form4.xml · derivative · entry 2 WENDELL PETER C · CIK 0001032635 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,698.5549 Underlying: Common Stock · 342.8742 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| June 25, 2019 Filed Jun 27, 2019 21:05 UTC |
Davis Robert MEVP, Global Svcs & CFO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 216,718 | $0.00 Strike: $59.86 | $0.00 |
DisclosureSEC source: 0001127602-19-022966 · form4.xml · derivative · entry 4 Davis Robert M · CIK 0001363076 · EVP, Global Svcs & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 216,718 shares Expires 2025-04-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The option became exercisable in equal installments on 5/1/2016, 5/1/2017 and 5/1/2018. Read SEC document |
| June 25, 2019 Filed Jun 27, 2019 21:05 UTC |
Davis Robert MEVP, Global Svcs & CFO
|
SaleCommon Stock | 26,550 | $86.00 | $2,283,345.14 |
DisclosureSEC source: 0001127602-19-022966 · form4.xml · nonDerivative · entry 3 Davis Robert M · CIK 0001363076 · EVP, Global Svcs & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 137,659.757 F1 · kind: The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $85.8500 to $86.2400, inclusive. The reporting person undertakes to provide to Merck & Co., Inc., any security holder of Merck & Co., Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above in this footnote. F4 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| June 25, 2019 Filed Jun 27, 2019 21:05 UTC |
Davis Robert MEVP, Global Svcs & CFO
|
SaleCommon Stock | 190,168 | $85.35 | $16,230,686.67 |
DisclosureSEC source: 0001127602-19-022966 · form4.xml · nonDerivative · entry 2 Davis Robert M · CIK 0001363076 · EVP, Global Svcs & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 164,209.757 F1 · kind: The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $84.8500 to $85.8400, inclusive. The reporting person undertakes to provide to Merck & Co., Inc., any security holder of Merck & Co., Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above in this footnote. Read SEC document |
| June 25, 2019 Filed Jun 27, 2019 21:05 UTC |
Davis Robert MEVP, Global Svcs & CFO
|
Exercise / conversionCommon Stock | 216,718 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-022966 · form4.xml · nonDerivative · entry 1 Davis Robert M · CIK 0001363076 · EVP, Global Svcs & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 354,377.757 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 31, 2019 Filed Jun 4, 2019 21:17 UTC |
Coe Mary EllenDirector
|
GrantPhantom Stock · Derivative | 2,335.5637 | $79.21 | $185,000.00 |
DisclosureSEC source: 0001104659-19-033845 · a4.xml · derivative · entry 2 Coe Mary Ellen · CIK 0001691304 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,470.7717 Underlying: Common Stock · 2,335.5637 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| May 31, 2019 Filed Jun 4, 2019 21:18 UTC |
BRUN LESLIE ADirector
|
GrantPhantom Stock · Derivative | 2,335.5637 | $79.21 | $185,000.00 |
DisclosureSEC source: 0001104659-19-033846 · a4.xml · derivative · entry 2 BRUN LESLIE A · CIK 0001217068 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,965.7657 Underlying: Common Stock · 2,335.5637 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| May 31, 2019 Filed Jun 4, 2019 21:18 UTC |
Cech Thomas RDirector
|
GrantPhantom Stock · Derivative | 2,335.5637 | $79.21 | $185,000.00 |
DisclosureSEC source: 0001104659-19-033847 · a4.xml · derivative · entry 2 Cech Thomas R · CIK 0001464680 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,731.8527 Underlying: Common Stock · 2,335.5637 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| May 31, 2019 Filed Jun 4, 2019 21:18 UTC |
GLOCER THOMAS HDirector
|
GrantPhantom Stock · Derivative | 2,335.5637 | $79.21 | $185,000.00 |
DisclosureSEC source: 0001104659-19-033848 · a4.xml · derivative · entry 2 GLOCER THOMAS H · CIK 0001140799 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,855.5787 Underlying: Common Stock · 2,335.5637 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| May 31, 2019 Filed Jun 4, 2019 21:19 UTC |
Craig Pamela J.Director
|
GrantPhantom Stock · Derivative | 2,335.5637 | $79.21 | $185,000.00 |
DisclosureSEC source: 0001104659-19-033849 · a4.xml · derivative · entry 2 Craig Pamela J. · CIK 0001232910 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,505.7257 Underlying: Common Stock · 2,335.5637 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| May 31, 2019 Filed Jun 4, 2019 21:19 UTC |
Rothman PaulDirector
|
GrantPhantom Stock · Derivative | 2,335.5637 | $79.21 | $185,000.00 |
DisclosureSEC source: 0001104659-19-033850 · a4.xml · derivative · entry 2 Rothman Paul · CIK 0001601332 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,505.7267 Underlying: Common Stock · 2,335.5637 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| May 31, 2019 Filed Jun 4, 2019 21:19 UTC |
LAZARUS ROCHELLE BDirector
|
GrantPhantom Stock · Derivative | 2,335.5637 | $79.21 | $185,000.00 |
DisclosureSEC source: 0001104659-19-033851 · a4.xml · derivative · entry 3 LAZARUS ROCHELLE B · CIK 0001082206 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,502.0837 Underlying: Common Stock · 2,335.5637 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| May 31, 2019 Filed Jun 4, 2019 21:20 UTC |
Wendell Peter CDirector
|
GrantPhantom Stock · Derivative | 2,335.5637 | $79.21 | $185,000.00 |
DisclosureSEC source: 0001104659-19-033852 · a4.xml · derivative · entry 2 WENDELL PETER C · CIK 0001032635 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,355.6807 Underlying: Common Stock · 2,335.5637 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| May 31, 2019 Filed Jun 4, 2019 21:20 UTC |
RUSSO PATRICIA FDirector
|
GrantPhantom Stock · Derivative | 2,335.5637 | $79.21 | $185,000.00 |
DisclosureSEC source: 0001104659-19-033853 · a4.xml · derivative · entry 2 RUSSO PATRICIA F · CIK 0001023219 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,062.1677 Underlying: Common Stock · 2,335.5637 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| May 31, 2019 Filed Jun 4, 2019 21:20 UTC |
THULIN INGE GDirector
|
GrantPhantom Stock · Derivative | 2,335.5637 | $79.21 | $185,000.00 |
DisclosureSEC source: 0001104659-19-033854 · a4.xml · derivative · entry 2 THULIN INGE G · CIK 0001263739 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,634.5557 Underlying: Common Stock · 2,335.5637 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| May 31, 2019 Filed Jun 4, 2019 21:21 UTC |
WEEKS WENDELL PDirector
|
GrantPhantom Stock · Derivative | 2,335.5637 | $79.21 | $185,000.00 |
DisclosureSEC source: 0001104659-19-033855 · a4.xml · derivative · entry 2 WEEKS WENDELL P · CIK 0001206158 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,295.4617 Underlying: Common Stock · 2,335.5637 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| May 10, 2019 Filed May 13, 2019 21:05 UTC |
Clyburn FrankEVP, Chief Commercial Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 4,389 | $78.33 | $343,790.37 |
DisclosureSEC source: 0001104659-19-028974 · a4.xml · derivative · entry 4 Clyburn Frank · CIK 0001763963 · EVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,389 shares Expires 2019-05-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock. Read SEC document |
| May 10, 2019 Filed May 13, 2019 21:05 UTC |
Clyburn FrankEVP, Chief Commercial Officer
|
Tax withholdingCommon Stock | 2,162 | $78.33 | $169,349.46 |
DisclosureSEC source: 0001104659-19-028974 · a4.xml · nonDerivative · entry 2 Clyburn Frank · CIK 0001763963 · EVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,831.087 F1 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| May 10, 2019 Filed May 13, 2019 21:05 UTC |
Clyburn FrankEVP, Chief Commercial Officer
|
Exercise / conversionCommon Stock | 4,389 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-19-028974 · a4.xml · nonDerivative · entry 1 Clyburn Frank · CIK 0001763963 · EVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,993.087 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 10, 2019 Filed May 13, 2019 21:05 UTC |
Fleming MichaelSVP Chief Ethics & Com Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 1,509 | $78.33 | $118,199.97 |
DisclosureSEC source: 0001104659-19-028976 · a4.xml · derivative · entry 3 Fleming Michael · CIK 0001772183 · SVP Chief Ethics & Com Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,509 shares Expires 2019-05-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock. Read SEC document |
| May 10, 2019 Filed May 13, 2019 21:05 UTC |
Fleming MichaelSVP Chief Ethics & Com Officer
|
Tax withholdingCommon Stock | 517 | $78.33 | $40,496.61 |
DisclosureSEC source: 0001104659-19-028976 · a4.xml · nonDerivative · entry 2 Fleming Michael · CIK 0001772183 · SVP Chief Ethics & Com Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,799.829 F1 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| May 10, 2019 Filed May 13, 2019 21:05 UTC |
Fleming MichaelSVP Chief Ethics & Com Officer
|
Exercise / conversionCommon Stock | 1,509 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-19-028976 · a4.xml · nonDerivative · entry 1 Fleming Michael · CIK 0001772183 · SVP Chief Ethics & Com Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,316.829 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 10, 2019 Filed May 13, 2019 21:06 UTC |
Nally MichaelEVP, Chief Marketing Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 1,811 | $78.33 | $141,855.63 |
DisclosureSEC source: 0001104659-19-028977 · a4.xml · derivative · entry 4 Nally Michael · CIK 0001763945 · EVP, Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,811 shares Expires 2019-05-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.